[Otitis and leukemia].
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D004428:Ear Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000601:surgery; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D007938:Leukemia / Q000150:complications*; D015470:Leukemia, Myeloid, Acute / Q000150:complications / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010031:Otitis / Q000188:drug therapy / Q000209:etiology* / Q000601:surgery; D010032:Otitis Externa / Q000188:drug therapy / Q000601:surgery; D011677:Punctures
D000970:Antineoplastic Agents; D005839:Gentamicins; D003561:Cytarabine; D003630:Daunorubicin
Otite et leucémie.